Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693238 · ClinicalTrials.gov registry record · NA
Proton Therapy for Low and Intermediate Risk Prostate Cancer
A NA study of Prostate Cancer, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
- 1
- Study location
NCT00693238: Completed NA study of Prostate Cancer, sponsored by University of Florida.
NCT00693238 is a NA study of Prostate Cancer that has completed, run by University of Florida. The registered enrollment target is 228 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00693238, a NA study of Prostate Cancer, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to give a shorter course (5 ½ weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.
Conditions Studied
Interventions
- RADIATION Low Risk Proton Radiation
- RADIATION Intermediate Risk Proton Radiation
Study Locations (1)
Florida
- University of Florida Proton Therapy Institute - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2008-04 |
| Est. Completion | 2022-04-25 |
| Phase | NA |
What the finished NCT00693238 record still lists
NCT00693238 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Low Risk Proton Radiation is the first listed.
NCT00693238 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00693238 about?
NCT00693238 is a clinical study titled "Proton Therapy for Low and Intermediate Risk Prostate Cancer". The purpose of this trial is to give a shorter course (5 ½ weeks) of radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of radiation, without decreasing the chance of killing prostate cancer cells.
What is the current status of trial NCT00693238?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2008-04. Estimated completion is 2022-04-25.
What conditions does trial NCT00693238 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00693238?
The interventions under investigation include: Low Risk Proton Radiation (RADIATION), Intermediate Risk Proton Radiation (RADIATION).
Who is sponsoring clinical trial NCT00693238?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00693238 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00693238's enrollment target sits among peer trials
228 200th of 735 higher than 536 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia